C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients

C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients

Background. Bladder cancer is one of the most common urinary malignancies. This study is aimed at providing some promising molecular biomarkers for bladder cancer (BC) by investigating the correlation between C1QTNF6 expression and clinical characteristics as well as prognosis in patients with bladd...

Full description

Bibliographic Details
Main Authors:	Xin Zhu, Hang Tong, Shun Gao, Hubin Yin, Gongmin Zhu, Xinyuan Li, Weiyang He, Xin Gou
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2020/7139721

Similar Items

A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer
by: Chen Zhang, et al.
Published: (2020-05-01)

Expression of a Secretory Protein C1qTNF6, a C1qTNF Family Member, in Hepatocellular Carcinoma
by: Tamotsu Takeuchi, et al.
Published: (2011-01-01)

Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer
by: M. Li, et al.

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
by: Chao Huang, et al.
Published: (2020-07-01)

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
by: Peng Zhang, et al.
Published: (2021-06-01)

IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer
by: Xin Hua, et al.
Published: (2021-01-01)

Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer
by: Wu J, et al.
Published: (2021-01-01)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
by: Zhu Z, et al.
Published: (2018-11-01)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
by: Binfeng Liu, et al.
Published: (2021-09-01)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
by: Jin Jingchun, et al.
Published: (2012-10-01)

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis
by: Chen Jing, et al.
Published: (2010-10-01)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
by: Junlong Wu, et al.
Published: (2017-08-01)

Overexpression of long noncoding RNA LINC00882 is associated with poor prognosis in hepatocellular carcinoma
by: Zhu L, et al.
Published: (2018-09-01)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
by: Yu Shuai, et al.
Published: (2021-03-01)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
by: Lu W, et al.
Published: (2020-11-01)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
by: Yibing Chen, et al.
Published: (2018-12-01)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
by: Shanglei Ning, et al.
Published: (2018-01-01)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
by: Chen JW, et al.
Published: (2018-01-01)

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
by: Huang CK, et al.
Published: (2018-04-01)

Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma
by: Run Shi, et al.
Published: (2017-03-01)

Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients
by: Xin Li, et al.
Published: (2021-05-01)

Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
by: Xiao-Fei Zhang, et al.
Published: (2016-12-01)

Predictors of poor prognosis in patients with COVID-19
by: Rubén González Tabares, et al.
Published: (2020-12-01)

Predictors of Poor Prognosis in Aluminum Phosphide Intoxication
by: Fakhredin Taghaddosi Nejad, et al.
Published: (2012-05-01)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
by: Yin X, et al.
Published: (2019-06-01)

Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
by: Xiao-Fei Zhang, et al.
Published: (2017-03-01)

Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients
by: Xin Zhang, et al.
Published: (2018-01-01)

Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer
by: Qing Ye, et al.
Published: (2015-01-01)

Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study
by: Chen H, et al.
Published: (2019-04-01)

Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
by: Siying Chen, et al.
Published: (2018-08-01)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
by: Tang XF, et al.
Published: (2019-01-01)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
by: Can Liu, et al.
Published: (2017-01-01)

GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2017-06-01)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
by: Jiang J, et al.
Published: (2021-03-01)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
by: Rui Zhu, et al.
Published: (2019-10-01)

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
by: Bennani Fadel, et al.
Published: (2009-01-01)

Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
by: Tingting Hu, et al.
Published: (2015-01-01)

Intestinal obstruction: predictor of poor prognosis in colorectal carcinoma?
by: Mohd Azri Mohd Suan, et al.
Published: (2015-03-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
by: Ling Wang, et al.
Published: (2018-07-01)

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
by: Chaojiang Chen, et al.
Published: (2020-04-01)